Sudarshan Pharma Industries Limited (BOM:543828)
India flag India · Delayed Price · Currency is INR
39.42
+0.40 (1.03%)
At close: Sep 4, 2026

BOM:543828 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
7,3227,0315,0504,6354,6133,571
Revenue Growth
32.86%39.21%8.95%0.48%29.19%84.52%
Gross Profit
923.03834.87651.92409.86303.72217.06
Operating Income
518.6484.87373.5224.48143.12101.5
Net Income
251.22233.03149.3114.5570.3752.48
Earnings Per Share
1.040.970.620.480.290.36
EPS Growth
20.14%56.18%29.17%64.16%-19.65%108.19%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
11.3511.3522.216.44117.192.36
Total Debt
2,8502,8501,7461,048341.04305.92
Net Cash (Debt)
-2,839-2,839-1,724-1,032-223.85-303.56
Net Cash Growth
------
Net Cash Per Share
-11.79-11.66-7.12-4.32-0.93-2.11

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--22.99-323.2496.86-287.93-38.22
Capital Expenditures
--690.97-212.45-37.84-143.27-16.56
Free Cash Flow
--713.96-535.6959.02-431.2-54.79
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
12.61%11.88%12.91%8.84%6.58%6.08%
Operating Margin
7.08%6.90%7.40%4.84%3.10%2.84%
Pretax Margin
4.46%4.34%3.96%3.29%2.06%2.00%
Profit Margin
3.43%3.31%2.96%2.47%1.52%1.47%
FCF Margin
--10.15%-10.61%1.27%-9.35%-1.53%

Dividends

Fiscal YearFY 2023
Period EndingMar '23
Dividend Per Share
0.030
Dividend Per Share Growth
-
Dividend Yield
0.54%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
37.7925.0349.2315.5713.64-
P/FCF Ratio
---30.22--
PS Ratio
1.300.831.460.390.21-